Delivery Order SPE2DB20D3101-SPE2DB25FRVU5
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 4, 2025. This non-set-aside contract represents a competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery will be fulfilled at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The place of performance is the company's corporate office location in...
- The Defense Logistics Agency awarded a $9,646 delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under contract 4569086102. This firm fixed price delivery order, issued on August 13, 2025, is part of a larger indefinite delivery contract (IDC) vehicle and represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVU5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply needs for military healthcare programs. AmerisourceBergen's DLA contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialty medications to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The award reflects the company's capability to fulfill federal medical procurement requirements through competitive processes and demonstrates its role as a critical distributor within the defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/17/25 |